Tq-B3525

HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 1/2

—

Rating in progress

Tq-B3525 in HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Dormant